U.S. Stocks Fall as Biotech, Commodity Shares Lead Broad Selloff

Updated on
  • Biotechnology rout continues to drag down health-care
  • Commodity related shares fall amid weakness in China

When Will Monetary Policy Distortion End?

U.S. stocks tumbled toward the worst levels of last month’s selloff, with the Standard & Poor’s 500 Index closing at a one-month low, as global equities slid amid a rout in commodity and biotechnology shares.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.